tifwp
-
Aug- 2007 -5 August
-
Nov- 2016 -5 NovemberTIF Publications
Prevention and Diagnosis of Haemoglobinopathies: A Short Guide for Health Professionals and Laboratory Scientists (2016)
Author: Old J. Reviewed by: Angastiniotis M., Petrou M., Traeger-Synodinos J.
Read More » -
Aug- 2017 -4 AugustEU Policies & Directives
Orphan Drugs
The Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency (EMA) is responsible for receiving, approving, and/or rejecting orphan…
Read More » -
4 AugustEU Policies & Directives
Rare Diseases
In EU countries, any disease affecting fewer than 5 people in 10 000 is considered rare. This number may seem…
Read More » -
4 AugustEU Policies & Directives
Cross-Border Healthcare
The Directive 2011/24/EU, clarifies that EU patients seeking healthcare outside their country may do so as long as the type…
Read More » -
4 AugustEU Policies & Directives
Clinical Trials
Best Practices Guidance for Clinical Trials In September 2024, the World Health Organization (WHO) released groundbreaking guidelines to strengthen…
Read More » -
4 AugustEU Policies & Directives
Pharmacovigilance
Phamacovigilance is defined as the activities that deal with the detection, assessment, understanding and prevention of adverse effects of medicinal…
Read More » -
4 AugustEU Policies & Directives
Patient Safety
Every year, millions of patients suffer injuries or die because of unsafe and poor-quality health care. Many medical practices and…
Read More » -
4 AugustEU Policies & Directives
Blood Safety & Availability
Blood Availability Great variability exists regarding availability of blood and blood donation practices among countries, influenced by socioeconomical factors. In…
Read More » -
2 August


